戻る Agenda
[V5-S3] Brain Storming How We Can Conduct Clinical Trials - A Company-Funded Company-Lead Trial is Not Only the Way to Run a Clinical Trial
Session Chair(s)
Tomoko Hirohashi, PHD
Director, Clinical Research Oncology
Pfizer Japan Inc., Japan
Speaker(s)
Brain Storming How We Can Concudt Clinical Trials? A Company-Funded Company-Lead Trials is Not Only the Way to Run a Clinical Trial? - Introduction
Tomoko Hirohashi, PHD
Pfizer Japan Inc., Japan
Director, Clinical Research Oncology
Clinical Development Strategy Including Company-Initiated Clinical Study
Tomio Nakamura
Eisai Co., Ltd., Japan
Senior Director, Japan/Asia Clinical Development Oncology Group
Drug development based on the collaboration between Academia and the companies- Proposal and requests from Academia-
Koichi Goto, MD, PHD
Daiichi Sankyo Company, Limited, Japan
Scientist, Medicinal Research Laboratories
Experience of Collaboration with External Partners - The Case of Non-Domestic Company -
Akihira Mukaiyama, MSC
GlaxoSmithKline K.K., Japan
Manager, Medicines Development, Development & Medical Afffairs Division